New genetic cause discovered for photosensitive blood disorder

The research team initially identified a family from Northern France in which the proband, or starting point for the genetic study of the family, suffered from EPP of unknown cause. The data collected from the proband indicated that she was affected by an unusual form of EPP. Among the proband's family members, only her father and uncle presented with indicators associated with mild photosensitivity but showed no clinical symptoms of EPP.
CLPX is a gene that controls mitochondrial unfoldase, an enzyme that carries out a balancing step in actively unfolds selected proteins for "protein quality control" during heme biosynthesis by catalytically activating the rate-limiting step enzyme, ALAS, or degrading ALAS protein. Researchers found that a dominant mutation in CLPX inherited by members of this family reduced the degradation associated with one of its target proteins, ALAS, which subsequently led to the accumulation of protoporphyrin IX (PPIX). Abnormal accumulation of PPIX is known to lead to EPP.
Past research by the team showed that there are several genes promoting PPIX overproduction and EPP including mitochondrial AAA+ unfoldase and ClpX. The current findings identify yet another gene promoting EPP and continue to expand the complex gene network that contributes to heme metabolism disorders.
"It is our hope that further understanding of the complex network of enzyme and cofactor interactions controlling heme synthesis will continue to contribute ideas for therapeutic strategies to treat diseases caused by aberrant regulation of heme metabolism," the authors write.


for more information visit our product website;Buy Fildena 100 mg Online


Location: United States

Comments

Post a Comment

Popular posts from this blog

Synaptic receptor mobility: Discovery of a new mechanism for controlling memory

Communication between neurons passes through over one million billion synapses, tiny structures the tenth of the width of a single hair, in an extremely complex process. Synaptic plasticity -- the ability of synapses to adapt in response to neuronal activity -- was discovered nearly 50 years ago, leading the scientific community to identify it as a vital functional component of memorization and learning. Neurotransmitter receptors -- found at the synapse level -- play a key role in the transmission of nerve messages. A few years ago, the team of researchers in Bordeaux discovered that neurotransmitter receptors were not immobile as thought previously, but in a constant state of agitation. They posited that controlling this agitation through neuronal activity could modulate the effectiveness of synaptic transmission by regulating the number of receptors present at a given time in a synapse. The new research has taken the two teams further in their understanding of the basic mecha...
Read more

Antidepressants associated with significantly elevated risk of death, researchers find

t's widely known that brain serotonin affects mood, and that most commonly used antidepressant treatment for depression  blocks the absorption of serotonin by neurons. It is less widely known, though, that all the major organs of the body -- the heart, kidneys, lungs, liver -- use serotonin from the bloodstream. Antidepressants block the absorption of serotonin in these organs as well, and the researchers warn that antidepressants could increase the risk of death by preventing multiple organs from functioning properly. The researchers reviewed studies involving hundreds of thousands of people and found that antidepressant users had a 33% higher chance of death than non-users. Antidepressant users also had a 14% higher risk of cardiovascular events, such as strokes and heart attacks. The findings were published in the journal  Psychotherapy and Psychosomatics . "We are very concerned by these results. They suggest that we shouldn't be taking antidepressant drugs wi...
Read more

Obese inducing brain mechanism

The research group of Professor Masaharu Noda, Associate Professor Takafumi Shintani, and a graduate student Satoru Higashi of the National Institute for Basic Biology (NIBB) demonstrated that protein tyrosine phosphatase receptor type J (PTPRJ) inhibits leptin signaling and that induction of PTPRJ in the hypothalamus is a cause of leptin resistance. They showed that Ptprj is expressed in hypothalamic neurons together with leptin receptors, and that PTPRJ inhibits activation of the leptin receptor through dephosphorylation of JAK2, a protein tyrosine kinase associated with the leptin receptor. Ptprj-deficient (Ptprj-KO) mice showed no growth retardation, but exhibited lower weight gain, because of a lower food intake and a lower adiposity, than wild-type (WT) mice. Importantly, PTPRJ expression in the hypothalamus was up-regulated by diet-induced obesity, and, thus, diet-induced leptin resistance did not occur in Ptprj-KO mice. Furthermore, the overexpression of PTPRJ in the hypot...
Read more